Premature ovarian insufficiency: an international menopause society white paper

N Panay, RA Anderson, RE Nappi, AJ Vincent… - …, 2020 - Taylor & Francis
The aim of this International Menopause Society White Paper on premature ovarian
insufficiency (POI) is to provide the latest information regarding this distressing condition …

Cognitive decline in early and premature menopause

M Sochocka, J Karska, M Pszczołowska… - International Journal of …, 2023 - mdpi.com
Early and premature menopause, or premature ovarian insufficiency (POI), affects 1% of
women under the age of 40 years. This paper reviews the main aspects of early and …

Premature ovarian insufficiency: a toolkit for the primary care physician

I Lambrinoudaki, SA Paschou, MA Lumsden… - Maturitas, 2021 - Elsevier
Premature ovarian insufficiency (POI) refers to the loss of ovarian activity before the age of
40 years, which leads to hypoestrogenism and amenorrhoea. The diagnosis of POI in a …

Natural history of ovarian function including assessment of ovarian reserve and premature ovarian failure

R Lew - Best practice & research Clinical obstetrics & …, 2019 - Elsevier
This chapter describes ovarian anatomy and embryology in humans. The formation of the
ovarian reserve is discussed, and events of folliculogenesis are described, including …

Tilapia skin peptides restore cyclophosphamide-induced premature ovarian failure via inhibiting oxidative stress and apoptosis in mice

YT Zhao, H Yin, C Hu, J Zeng, X Shi, S Chen… - Food & Function, 2022 - pubs.rsc.org
Tilapia (Oreochromis mossambicus) skin high value-added compounds have not been fully
utilized in tilapia processing. Here, the protective effects of tilapia skin peptides (TSP) on …

Fertility preservation for genetic diseases leading to premature ovarian insufficiency (POI)

A La Marca, E Mastellari - Journal of assisted reproduction and genetics, 2021 - Springer
Purpose The current review aims to summarize the data available concerning the
applicability of fertility preservation techniques to genetic conditions at risk of premature …

Research progress on the treatment of premature ovarian failure using mesenchymal stem cells: a literature review

J Wang, W Liu, D Yu, Z Yang, S Li… - Frontiers in Cell and …, 2021 - frontiersin.org
Premature ovarian failure (POF) has become one of the main causes of infertility in women
of childbearing age and the incidence of POF is increasing year by year, seriously affecting …

Current and future treatments for classic galactosemia

B Delnoy, AI Coelho, ME Rubio-Gozalbo - Journal of Personalized …, 2021 - mdpi.com
Type I (classic) galactosemia, galactose 1-phosphate uridylyltransferase (GALT)-deficiency
is a hereditary disorder of galactose metabolism. The current therapeutic standard of care, a …

[HTML][HTML] Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure

J Shen, D Cao, JL Sun - World journal of stem cells, 2020 - ncbi.nlm.nih.gov
BACKGROUND Premature ovarian insufficiency (POI) and premature ovarian failure (POF)
have become one of the major problems threatening women of childbearing age. Studies …

Primary amenorrhea and premature ovarian insufficiency

SA Yatsenko, SF Witchel… - … and Metabolism Clinics, 2024 - endo.theclinics.com
Background HH typically reflects gonadal dysfunction. One cause of HH is POI. POI is
associated with ovarian dysgenesis, accelerated depletion of primordial follicles, or ovarian …